Onco-Innovations (FRA:W1H) OCF Margin %: -4,507.69% (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:W1H Onco-Innovations Ltd FRA:W1H
20 GF Score
Price €0.34
! 2 Warning Signs
View Full Analysis

What is Onco-Innovations OCF Margin %?

Onco-Innovations FRA:W1H -0.73% 20 OCF Margin % is -4,507.69% as of Apr. 2026. GuruFocus rates FRA:W1H with a GF Score™ of 20/100. The stock has 2 warning signs investors should review. Among 957 Biotechnology companies, Onco-Innovations ranks worse than 90.8% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Onco-Innovations's Cash Flow from Operations for the three months ended in Apr. 2026 was €-0.59 Mil. Onco-Innovations's Revenue for the three months ended in Apr. 2026 was €0.01 Mil. Therefore, Onco-Innovations's OCF Margin % for the quarter that ended in Apr. 2026 was -4,507.69%.

As of today, Onco-Innovations's current OCF Yield % is -13.77%.

The historical rank and industry rank for Onco-Innovations's OCF Margin % or its related term are showing as below:

FRA:W1H' s OCF Margin % Range Over the Past 10 Years
Min: -5952.31   Med: -5370.7   Max: -4789.09
Current: -4734.78

During the past 4 years, the highest OCF Margin % of Onco-Innovations was -4789.09%. The lowest was -5952.31%. And the median was -5370.70%.

FRA:W1H's OCF Margin % is ranked worse than
90.8% of 957 companies
in the Biotechnology industry
Industry Median: -70.9 vs FRA:W1H: -4734.78

Onco-Innovations OCF Margin % Related Terms

Onco-Innovations OCF Margin % Historical Data

* Premium members only.

The historical data trend for Onco-Innovations's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onco-Innovations OCF Margin % Chart

Onco-Innovations Annual Data
Trend Apr23 Apr24 Apr25 Apr26
OCF Margin %
0.00 0.00 -6,007.32 -4,816.18

Onco-Innovations Quarterly Data
Apr23 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,843.90 -9,430.77 -2,558.14 0.00 -4,507.69

FRA:W1H vs VRTX, REGN, RVMD: OCF Margin % Comparison

For the Biotechnology subindustry, Onco-Innovations's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Onco-Innovations OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Onco-Innovations's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Onco-Innovations's OCF Margin % falls into.


FRA:W1H
20GF Score
Onco-Innovations Ltd FRA:W1H
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onco-Innovations OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Onco-Innovations's OCF Margin for the fiscal year that ended in Apr. 2026 is calculated as

OCF Margin=Cash Flow from Operations (A: Apr. 2026 )/Revenue (A: Apr. 2026 )
=-3.275/0.068
=-4,816.18 %

Onco-Innovations's OCF Margin for the quarter that ended in Apr. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Apr. 2026 )/Revenue (Q: Apr. 2026 )
=-0.586/0.013
=-4,507.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -4,507.69% mean?
Onco-Innovations (FRA:W1H) has a OCF Margin % of -4,507.69% as of Apr. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Onco-Innovations and its competitors. According to the industry distribution chart, Onco-Innovations ranks #869 out of 957 companies in the Biotechnology industry, placing it in the top 90.8%.
Is Onco-Innovations' OCF Margin % too high?
Onco-Innovations' current OCF Margin % is -4,507.69%. Based on the distribution chart, Onco-Innovations ranks #869 out of 957 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Onco-Innovations has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Onco-Innovations' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Onco-Innovations ranks #869 out of 957 companies for OCF Margin %. This places Onco-Innovations in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Onco-Innovations and its competitors. Onco-Innovations's current OCF Margin % is -4,507.69%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onco-Innovations stock overvalued right now?
Onco-Innovations (FRA:W1H) has a current OCF Margin % of -4,507.69%. The current OCF Margin % is -4,507.69%. Onco-Innovations' overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Onco-Innovations (FRA:W1H), the current OCF Margin % is -4,507.69% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Onco-Innovations Business Description

Other Exchanges W1H:GermanyONCO:Canada
Address 7th Street South West, Suite 1039, Calgary, AB, CAN, T2R 1A5
Onco-Innovations Ltd is a pre-clinical stage biotechnology company working on developing drug candidates that can increase the effectiveness of current cancer treatments.
20GF Score

Get the complete analysis for FRA:W1H

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.34
Price